GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotoscana Investments SA (BSP:GBIO33) » Definitions » Current Deferred Revenue

Biotoscana Investments (BSP:GBIO33) Current Deferred Revenue : R$0.0 Mil (As of Jun. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Biotoscana Investments Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Biotoscana Investments's current deferred revenue for the quarter that ended in Jun. 2020 was R$0.0 Mil.

Biotoscana Investments Current Deferred Revenue Historical Data

The historical data trend for Biotoscana Investments's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotoscana Investments Current Deferred Revenue Chart

Biotoscana Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Biotoscana Investments Quarterly Data
Dec14 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotoscana Investments Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Biotoscana Investments's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotoscana Investments (BSP:GBIO33) Business Description

Traded in Other Exchanges
N/A
Address
70 route d’Esch, Luxembourg, LUX, 1470
Biotoscana Investments SA is a biopharmaceutical company. It is engaged in the manufacturing, development, and sale of pharmaceutical products. Its areas of operations are oncology, on-hematology, severe infectious diseases, and genetic and rare condition.

Biotoscana Investments (BSP:GBIO33) Headlines

No Headlines